Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID2031 | SLDRNLPSDSQDLGQHGLEED | Secretory granule proteoglycan core protein | Serum | 2324.05166 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID2032 | SLDRNLPSDSQDLGQHGLEEDFM | Secretory granule proteoglycan core protein | Serum | 2602.16056 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID2033 | SLDRNLPSDSQDLGQHGLEEDF | Secretory granule proteoglycan core protein | Serum | 2471.12007 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID2034 | NLPSDSQDLGQHGLEED | Secretory granule proteoglycan core protein | Serum | 1852.80751 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID2035 | SLDRNLPSDSQDLGQHGLEEDFML | Secretory granule proteoglycan core protein | Serum | 2715.24462 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID9875 | DRNLPSDSQDLGQHG | Serglycin | Serum | 546.91 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9876 | SLDRNLPSDSQDLGQHG | Serglycin | Serum | 613.61 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9877 | NLPSDSQDLGQHGLEED | Serglycin | Serum | 927.38 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9878 | SLDRNLPSDSQDLGQHGLEED | Serglycin | Serum | 775.68 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9879 | SLDRNLPSDSQDLGQHGLEEDFM | Serglycin | Serum | 873.71 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9880 | SLDRNLPSDSQDLGQHGLEEDFM | Serglycin | Serum | 868.4 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |